Primary Care Pod podcast

New(ish) Drug for MACE Prevention

0:00
15:30
Recuar 15 segundos
Avançar 15 segundos

Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention).  NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.

 

 

Mais episódios de "Primary Care Pod"